ror,sponsor_name,sponsor_article,number_of_trials,staff_10_years,indicator_10_years,staff_10_years_drug,indicator_10_years_drug,staff_10_years_last_year,indicator_10_years_last_year,staff_10_years_last_year_drug,indicator_10_years_last_year_drug,staff_10_years_france,indicator_10_years_france,staff_10_years_drug_france,indicator_10_years_drug_france,staff_10_years_last_year_france,indicator_10_years_last_year_france,staff_10_years_last_year_drug_france,indicator_10_years_last_year_drug_france
01kv58h76,ANRS Maladies infectieuses Ã©mergentes,de l',102,39,49 %,18,72 %,39,10 %,18,17 %,9703,51 %,3667,76 %,9703,32 %,3667,53 %
